Drug intelligence / Profile preview

Mamuran

Development stage
Unknown
Lead developer
Xinjiang Uygur Pharmaceutical
Administration
Oral
01

Overview

Mamuran (also known as Mamuran Zhixie Capsules or Ma-Mu-Ran) is a Traditional Uyghur Patent Medicine (TUPM) approved by the China Food and Drug Administration (CFDA) for the treatment of diarrhea, abdominal pain, vomiting, and indigestion associated with acute enteritis, bacillary dysentery, and ulcerative colitis. It is a multi-herb compound preparation composed of 14 traditional medicines, including Coptidis Rhizoma, Draconis Sanguis, Olibanum, Turkish Galls, Bambusae Concretio Silicea, Semen Plantaginis Psyllii, Chebulae Fructus Immaturus, Fructus Berberis, Fructus Coriandri, Chebulae Fructus, Terminalise Belliricae Fructus, Flos Granati, Granati Pericarpium, and Gummi Tragacanthae. Mamuran exerts its therapeutic effects by regulating host metabolism and modulating the gut microbiota, particularly by restoring the abundance of beneficial bacteria such as Lactobacillus and Bifidobacterium. Its primary active components, berberine hydrochloride and gallic acid, provide potent anti-inflammatory, antimicrobial, and mucosal protective properties.

Brand names
MamuranMamuran Zhixie CapsulesMamuran Zhixie GranulesMamuran Zhixie Jiaonang玛木然止泻胶囊
Other names
Ma-Mu-RanMa-Mu-Ran Antidiarrheal CapsulesMamuran Antidiarrheal Capsules

Beyond the preview

Go deeper on Mamuran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mamuran.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call